Regenerative Medicine

The FDA has granted Regenerative Medicine Advanced Therapy designation to an autologous, fully human CD19 chimeric antigen receptor T-cell therapy candidate, to treat those with progressive myasthenia gravis.

The FDA has granted Regenerative Medicine Advanced Therapy designation to a novel regenerative cell therapy to treat drug-resistant mesial temporal lobe epilepsy, according to the manufacturer.

The FDA granted breakthrough therapy and regenerative medicine advanced therapy designations for AURN001 for the treatment of corneal edema secondary to corneal endothelial disease, according to a press release from Aurion Biotech.

The FDA has granted regenerative medicine advanced therapy designation for an investigational gene therapy to treat Huntington’s disease, according to the manufacturer.

The FDA has granted regenerative medicine advanced therapy designation to an intrathecally delivered AAV9 gene transfer therapy to treat younger individuals with Rett syndrome, according to the manufacturer.

In an interactive panel at the Twin Cities Ocular Surface Disease Symposium, speakers and attendees shared insight and experience with different treatment options and procedural techniques for patients with ocular surface disease.

University of Colorado Medicine has announced the launch of the CU Medicine Regenerative Medicine, Hand and Spine Center, according to a press release.

MIAMI BEACH, Fla. — Although they should never be injected, exosomes could change the way dermatologists heal the skin, according to a speaker at South Beach Symposium.

MIAMI BEACH, Fla. — During a presentation on genomics in regenerative medicine at South Beach Symposium, a speaker highlighted the impending release of clinical trial data as well as the start of a second trial that may advance the field.

Irving Weissman, MD, will receive the Wallace H. Coulter Award for Lifetime Achievement in Hematology at this year’s ASH Annual Meeting & Exposition.